Feb 10 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2021 Dec 31, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 45.66 29.55 65.00
(+54.5 pct) (+20.3 pct) (+41.0 pct)
Operating 19.93 8.79 26.00
(+126.7 pct) (+126.6 pct) (+86.3 pct)
Recurring 20.15 8.92 26.20
(+126.0 pct) (+128.9 pct) (+85.0 pct)
Net 14.36 5.73 18.50
(+150.8 pct) (+111.4 pct) (+93.8 pct)
EPS 119.29 yen 47.56 yen 153.63 yen
Ann Div 16.00 yen 30.00 yen
-Q2 div NIL NIL
-Q4 div 16.00 yen 30.00 yen
NOTE - Takara Bio Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T